Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.S. FDA okays expanded use of Medivation prostate cancer drug
Yahoo/Reuters
Wednesday, September 10, 2014 - 6:26pm
tags:
Medivation, FDA, prostate cancer, Xtandi
Pfizer Inc. Trying To Claw Its Way Back Up After Pullback
Yahoo/Benzinga
Wednesday, September 10, 2014 - 12:02pm
tags:
Pfizer
ViiV’s Triumeq to end Gilead’s monopoly in HIV
Pharmaphorum
Wednesday, September 10, 2014 - 11:33am
tags:
ViiV Healthcare, Gilead Sciences, HIV, Triumeq
IPO Filing: Xenon Pharmaceuticals
Yahoo/24-7 Wall St
Wednesday, September 10, 2014 - 11:20am
tags:
IPOs, Xenon
Sanofi Announces $2.5 Million Contribution to Dementia Research
Yahoo
Wednesday, September 10, 2014 - 11:18am
tags:
Sanofi, dementia
Lilly receives European approval for long-lasting insulin targeted for litigation by Sanofi
Yahoo/AP
Wednesday, September 10, 2014 - 11:17am
tags:
Eli Lilly, Europe, insulin, diabetes, Sanofi
New Study Says Common Anxiety Medications Like Xanax, Valium and Klonopin May Increase Risk Of Alzheimer's Disease
Forbes
Wednesday, September 10, 2014 - 10:16am
tags:
Xanax, benzodiazepines, Valium, Alzheimer's disease
Valeant And Allergan: The Saga Continues
Bidness Etc.
Wednesday, September 10, 2014 - 10:02am
tags:
Valeant Pharmaceuticals, Allergan, M&A, Bill Ackman
Free speech, PhRMA? Not in this off-label marketing case, feds say
Fierce Pharma Marketing
Wednesday, September 10, 2014 - 9:56am
tags:
off-label, free speech, PhRMA, Millennium Pharmaceuticals, whistleblower lawsuits
Not Every Conflict of Interest Produces the Same Vote on FDA Panels
WSJ Pharmalot
Wednesday, September 10, 2014 - 9:49am
tags:
FDA, advisory panels, conflict-of-interest
Lawsuits claiming Merck lied about mumps vaccine efficacy headed to trial
Fierce Vaccines
Wednesday, September 10, 2014 - 9:46am
tags:
Merck, vaccines, mumps
Prepping for a tax-cutting merger, Auxilium is axing about 200 staffers
Fierce Biotech
Wednesday, September 10, 2014 - 9:01am
tags:
Auxilium, M&A, layoffs, QLT
FDA staff: NPS drug effective; no significant safety imbalance
Yahoo/Reuters
Wednesday, September 10, 2014 - 8:59am
tags:
NPS Pharmaceuticals, FDA, Natpara, hypoparathyroidism
Retrophin Assailed for 'Exorbitant' Drug-Price Hike
TheStreet.com
Wednesday, September 10, 2014 - 8:58am
tags:
Retrophin, drug pricing, Theola, cystinuria
Peregrine Pharmaceuticals' Q1 Loss Wider than Expected
Yahoo/Zacks.com
Wednesday, September 10, 2014 - 8:55am
tags:
Peregrine Pharmaceuticals, earnings
Aspen Profit Climbs as Glaxo, Merck Purchases Fuel Growth
Bloomberg
Wednesday, September 10, 2014 - 8:53am
tags:
Aspen Pharmacare, generics, Merck, GSK, Africa
Actavis Blood Pressure Pill Not Backed by U.S. Advisers
Bloomberg
Tuesday, September 9, 2014 - 6:27pm
tags:
Actavis, FDA, hypertension
ACKMAN: Allergan Has The 'Most Shareholder-Unfriendly' Defense In The 'History Of Corporate America'
Business Insider
Tuesday, September 9, 2014 - 6:26pm
tags:
Bill Ackman, Allergan, Valeant Pharmaceuticals, M&A
Teva Pharmaceuticals New Drug Aims to Reduce Asthma Attacks
Motley Fool
Tuesday, September 9, 2014 - 10:49am
tags:
Teva Pharmaceutical, asthma, reslizumab
Hospitals kick orthopedic sales reps out of the OR
Mass Device
Tuesday, September 9, 2014 - 10:45am
tags:
devices, hospitals, Orthopedics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.